# Cerus Corporation (CERS) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare. Price $2.59, market value $522 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Cerus Corporation reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 2.2×**. Each dollar of revenue is priced at 2.2×.
- **Price / book: 7.4×**. The shares trade at 7.4× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: -0.4%** (5-yr avg -3.3%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Operating margin: -3.7%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -6.7%**. The company reported a net loss over the last twelve months.
- **Return on equity: -24.3%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -10.7%**. Return on all capital, debt included, is -10.7%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -7.0%**. Each dollar of assets produces -7.0% of profit.

## Growth
- **Revenue growth (1 yr): 16.1%** (3-yr 7.5%/yr, 5-yr 15.4%/yr). Revenue grew 16.1% over the last year, against 15.4% a year compounded over five years.
- **EPS growth (1 yr): 27.3%**. Earnings per share rose 27.3%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.31**. Debt is 0.31 times equity: a conservative balance sheet.
- **Net debt / EBITDA: net cash**. Cerus Corporation holds more cash than debt.
- **Current ratio: 1.73** (quick 1.73). Current assets cover the next year's liabilities 1.73 times.
- **Altman Z-score: 3.72**. A Z-score of 3.72 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Cerus Corporation does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (4 analysts). 4 analysts cover Cerus Corporation; the consensus is strong_buy, with an average price target of $5.13 (+98% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 94.7%** (YTD 25.7%, 3-mo -4.4%). The shares are up 94.7% over twelve months including dividends.
- **From 52-week high: -25.4%** (121.4% above the low). Trading 25% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 44**. An RSI of 44 is neutral.
- **Beta (1 yr): 1.51** (volatility 79%). Beta of 1.51 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=CERS · Page: https://foliofundamentals.com/stocks/cers

Not investment advice.